摘要
目的:探讨原发性肝癌合并门静脉高压症的手术方法及疗效。方法:回顾分析手术治疗原发性肝癌合并门静脉高压症120例资料。结果:手术并发症和手术病死率分别是18.5%和5.6%。术后1,3,5,7年生存率分别是79.5%,40.6%,35.2%,9.3%。结论:个体化治疗原则是提高原发性肝癌合并门静脉高压症治疗效果的关键。
Objective : To investigate the operation approaches and their effects for HCC patients with portal hypertension. Methods: The records of 120 patients with HCC and portal hypertension were retrospectively examined. Results: Operative morbidity and mortality rates were 18.5% and 5.6%. The 1-, 3-, 5- and 7-year survival rates were 79.5%, 40.6%, 35.2% and 9.3%, respectively. Conclusion: For HCC patients with portal hypertension, the choice of operative approaches according to individuation play a critical rule in reducing operation complications and improving survival rate.
出处
《华夏医学》
CAS
2009年第4期607-608,共2页
Acta Medicinae Sinica
关键词
肝细胞癌
门静脉高压症
手术
hepatocellular carcinoma
portal hypertension
surgery